- Overview of PKD Pathobiology
- Management of ADPKD in 2018
- Tolvaptan and Beyond
- Building Partnership with Patients to Enhance Clinical Care
- Mini symposium on “Metabolic Syndrome, Obesity, and PKD”
Day 2: Sept 15, 2018 8:00 am to 1:00 pm
- Risk Assessment by Genetic Testing
- Total Kidney Volume (TKV) Measurements – Utility and Nuances
- Foam Sclerotherapy for Cystic Kidney Volume Reduction
- Modern Management of ADPKD in UK and Europe
- Experience from the Centre for Innovation Management of PKD (CIMPKD)
- Interactive Case Presentations with Expert Panel
https://www.dropbox.com/scl/fo/kgqhfkprqv1c1rept2mha/h?rlkey=72fxa54wim7wjtdknb6keohnk&dl=0
Chestnut Residence and Conference Centre, Toronto, ON